The Cell Culture Dish
This week’s headlines include: Scientists report progress on “liquid biopsies” for cancer screening, FDA approves Pfizer’s drug for rare blood cancer, Takeda R&D reboot continues with Stanford drug discovery deal, MilliporeSigma to Be Granted...
This week’s headlines include: Heart and Asthma Monitors? There’s an App for That, Kite Pharma Submits IND for BCMA-Targeting CAR-T Cancer Immunotherapy, FDA Finalizes 46 Bioequivalence Guidances, Rare leukemia targeted by modifying patients’...
Scientists used a novel live-cell fluorescent imaging system that allowed them for the first time to identify individual viral particles associated with HIV infection.
Researchers have identified the mechanism behind red blood cell specialization and revealed that it is controlled by an enzyme called UBE2O. This finding could spark the development of new treatments for blood disorders and cancers.
Thanks, Tim, for bringing the wonder back into science for me again!"
Momenta Pharmaceuticals, Inc.